Beta-Alanine and Your Liver and Kidneys: Is It Safe?
Beta-alanine is one of the few supplements with solid evidence for improving performance in high-intensity efforts. Its famous side effect, a harmless tingling of the skin, makes many users wonder what else it might be doing inside the body. Our editorial team examined what the research says about beta-alanine and the two organs people worry about most: the liver and the kidneys.
How beta-alanine works
Beta-alanine is a non-essential amino acid that the body combines with histidine to form carnosine. Carnosine is stored mainly in skeletal muscle, where it acts as a buffer against the acid that accumulates during intense exercise. More carnosine means the muscle can tolerate high-intensity work a little longer before fatigue sets in.
Supplementation raises muscle carnosine content substantially. Harris and colleagues (2006) demonstrated that oral beta-alanine increased carnosine in the vastus lateralis muscle, and later studies showed increases of roughly 40 to 80 percent over several weeks, depending on the total amount consumed.
Performance benefits are clearest in efforts lasting about one to four minutes. Meta-analyses by Hobson and colleagues (2012) and Saunders and colleagues (2017) concluded that beta-alanine produces small but meaningful improvements in exercise capacity in this range.
Unlike stimulants, beta-alanine works through accumulation, not acute effects. It takes several weeks of daily intake to load muscle carnosine, and levels decline gradually after stopping.
Where safety concerns come from
The most noticeable effect is paresthesia, a tingling or prickling sensation on the face, neck and hands that appears 10 to 20 minutes after a dose and fades within an hour or so. It is caused by activation of specific sensory nerve receptors and is not a sign of nerve damage or an allergic reaction.
Some concerns come from the general idea that "amino acid supplements strain the kidneys" or that anything processed by the liver must stress it. These worries are often carried over from discussions about high-protein diets or anabolic steroids, which are entirely different issues.
A more specific theoretical concern involves taurine. Beta-alanine and taurine share a transporter, so very high beta-alanine intake could reduce taurine uptake into tissues. Animal studies using extreme doses have shown taurine depletion, but human studies at typical doses have not shown clinically relevant effects.
Finally, there is limited long-term data beyond about six months. Absence of evidence of harm is not the same as proof of safety over many years, and that caveat applies to most supplements.
What studies show for the liver
Beta-alanine is not primarily processed in a way that places a heavy load on the liver. Most of it is either used to build carnosine in muscle or metabolized through normal amino acid pathways.
In clinical trials that measured liver markers, beta-alanine has not been associated with harmful changes. A comprehensive systematic risk assessment and meta-analysis by Dolan and colleagues (2019) reviewed 101 studies and found no evidence that beta-alanine supplementation adversely affected circulating biomarkers of health, including markers related to liver function, at the doses studied.
A 24-week study by Saunders and colleagues (2017) monitored participants taking beta-alanine and reported no adverse effects on clinical blood markers over that period. This is among the longest controlled human exposures available.
That said, people with existing liver disease were generally excluded from these trials. Their situation is different, and decisions about any supplement should involve their hepatologist.
What studies show for the kidneys
Kidney function is usually assessed with serum creatinine, blood urea nitrogen and estimated glomerular filtration rate. In the trials included in the Dolan meta-analysis, these markers did not change in a clinically meaningful way with beta-alanine.
The International Society of Sports Nutrition position stand on beta-alanine (Trexler et al., 2015) concluded that supplementation appears safe in healthy populations at recommended doses, with paresthesia being the only commonly reported side effect.
| Question | Current evidence |
|---|---|
| Does it raise liver enzymes in healthy people? | Not in controlled trials at standard doses |
| Does it impair kidney function markers? | No consistent changes reported |
| Is long-term use proven safe? | Data extend to about 24 weeks; longer use is less studied |
| Is tingling dangerous? | No; it is a harmless sensory effect |
| Is it safe with kidney disease? | Not studied; requires medical advice |
One practical point concerns creatinine. If beta-alanine is combined with creatine, as is common, creatine can raise serum creatinine slightly without any actual kidney damage, because creatinine is a breakdown product of creatine. Tell your doctor about supplements before blood tests to avoid misinterpretation.
People with chronic kidney disease, a single kidney or a history of kidney stones were not adequately represented in research. They should consult a nephrologist before adding beta-alanine or other supplements.
Who should be careful and how to use it
For healthy adults, beta-alanine has a reassuring safety profile. Groups for whom data are lacking include pregnant and breastfeeding women, adolescents and people with chronic liver or kidney disease.
The ISSN recommends a daily intake of about 4 to 6 grams, typically split into doses of 2 grams or less to reduce tingling. Sustained-release formulations also help minimize paresthesia. Loading for at least 2 to 4 weeks is needed to raise muscle carnosine meaningfully.
- Split the daily amount into 3–4 smaller doses taken with meals.
- Consider a sustained-release form if tingling is bothersome.
- Consistency matters more than timing around workouts.
- Mention supplements to your doctor before routine blood work.
Choose a product that has been independently tested, especially if you compete in drug-tested sport. Beta-alanine itself is not prohibited by WADA, but pre-workout products containing it sometimes include undeclared stimulants.
The Editorial Team's Conclusions
Current evidence does not show that beta-alanine harms the liver or kidneys in healthy people at recommended doses. A large systematic risk assessment found no adverse changes in standard health biomarkers.
The familiar tingling is harmless and can be reduced by smaller, split doses or sustained-release formulations.
The main gaps are long-term data beyond six months and data in people with existing organ disease, who should seek medical advice first.
If this was useful, you may also want to read our articles on creatine and kidney health, on carnosine and muscle buffering, and on interpreting creatinine results in athletes.
References
- Dolan E, Swinton PA, Painelli VS, et al. A systematic risk assessment and meta-analysis on the use of oral β-alanine supplementation. Adv Nutr. 2019;10(3):452–463.
- Trexler ET, Smith-Ryan AE, Stout JR, et al. International Society of Sports Nutrition position stand: beta-alanine. J Int Soc Sports Nutr. 2015;12:30.
- Harris RC, Tallon MJ, Dunnett M, et al. The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids. 2006;30(3):279–289.
- Hobson RM, Saunders B, Ball G, et al. Effects of β-alanine supplementation on exercise performance: a meta-analysis. Amino Acids. 2012;43(1):25–37.
- Saunders B, Elliott-Sale K, Artioli GG, et al. β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med. 2017;51(8):658–669.
- Saunders B, de Salles Painelli V, de Oliveira LF, et al. Twenty-four weeks of β-alanine supplementation on carnosine content, related genes, and exercise. Med Sci Sports Exerc. 2017;49(5):896–906.
